Skip to content
Medical Health Aged Care

Vale John Daffey FPS

Pharmaceutical Society of Australia (PSA) < 1 mins read

The Pharmaceutical Society of Australia (PSA) is deeply saddened to hear of the passing of former National President John Daffey FPS.  

Mr Daffey served as PSA’s National President between 2000 and 2001, on top of his 15 years of service on PSA’s Victorian Branch from 1987 to 2002.   

PSA National President Dr Fei Sim FPS expressed her deepest condolences to Mr Daffey’s colleagues, family, friends and loved ones.   

“John made many valuable contributions to our profession, both as a community pharmacist and as a national leader,” Dr Sim said.   

“John is well known for his leadership and collegiality throughout negotiations for the 3rd Community Pharmacy Agreement, working collaboratively with the Pharmacy Guild of Australia to get the best outcomes for Australian pharmacists and patients.  

“His loss comes at a difficult time for pharmacists around Australia, and there has never been a more important time for our profession to unite in John’s spirit of solidarity.  

“On behalf of the pharmacy profession, my deepest condolences are with the Daffey family, their friends, and many colleagues in Victoria,” Dr Sim concluded. 

 

Media contact:   Georgia Clarke   M: 0480 099 798      E: georgia.clarke@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17
Aegros

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.